chr15-91002014-C-T
Variant names:
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_018668.5(VPS33B):c.1405+36G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00612 in 1,612,852 control chromosomes in the GnomAD database, including 500 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Genomes: 𝑓 0.031 ( 253 hom., cov: 31)
Exomes 𝑓: 0.0035 ( 247 hom. )
Consequence
VPS33B
NM_018668.5 intron
NM_018668.5 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: -1.54
Genes affected
VPS33B (HGNC:12712): (VPS33B late endosome and lysosome associated) Vesicle mediated protein sorting plays an important role in segregation of intracellular molecules into distinct organelles. Genetic studies in yeast have identified more than 40 vacuolar protein sorting (VPS) genes involved in vesicle transport to vacuoles. This gene is a member of the Sec-1 domain family, and encodes the human ortholog of rat Vps33b which is homologous to the yeast class C Vps33 protein. The mammalian class C vacuolar protein sorting proteins are predominantly associated with late endosomes/lysosomes, and like their yeast counterparts, may mediate vesicle trafficking steps in the endosome/lysosome pathway. Mutations in this gene are associated with arthrogryposis-renal dysfunction-cholestasis syndrome. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jan 2014]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.87).
BP6
Variant 15-91002014-C-T is Benign according to our data. Variant chr15-91002014-C-T is described in ClinVar as [Likely_benign]. Clinvar id is 261039.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.104 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
VPS33B | NM_018668.5 | c.1405+36G>A | intron_variant | Intron 18 of 22 | ENST00000333371.8 | NP_061138.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
VPS33B | ENST00000333371.8 | c.1405+36G>A | intron_variant | Intron 18 of 22 | 1 | NM_018668.5 | ENSP00000327650.4 | |||
ENSG00000284946 | ENST00000643536.1 | n.1405+36G>A | intron_variant | Intron 18 of 34 | ENSP00000494429.1 |
Frequencies
GnomAD3 genomes AF: 0.0309 AC: 4700AN: 152184Hom.: 249 Cov.: 31 show subpopulations
GnomAD3 genomes
AF:
AC:
4700
AN:
152184
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.00858 AC: 2157AN: 251334 AF XY: 0.00639 show subpopulations
GnomAD2 exomes
AF:
AC:
2157
AN:
251334
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00353 AC: 5151AN: 1460550Hom.: 247 Cov.: 32 AF XY: 0.00317 AC XY: 2302AN XY: 726576 show subpopulations
GnomAD4 exome
AF:
AC:
5151
AN:
1460550
Hom.:
Cov.:
32
AF XY:
AC XY:
2302
AN XY:
726576
show subpopulations
African (AFR)
AF:
AC:
3750
AN:
33436
American (AMR)
AF:
AC:
259
AN:
44714
Ashkenazi Jewish (ASJ)
AF:
AC:
37
AN:
26126
East Asian (EAS)
AF:
AC:
2
AN:
39692
South Asian (SAS)
AF:
AC:
303
AN:
86178
European-Finnish (FIN)
AF:
AC:
1
AN:
53372
Middle Eastern (MID)
AF:
AC:
34
AN:
4858
European-Non Finnish (NFE)
AF:
AC:
285
AN:
1111882
Other (OTH)
AF:
AC:
480
AN:
60292
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.487
Heterozygous variant carriers
0
264
529
793
1058
1322
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
GnomAD4 genome AF: 0.0310 AC: 4725AN: 152302Hom.: 253 Cov.: 31 AF XY: 0.0305 AC XY: 2269AN XY: 74462 show subpopulations
GnomAD4 genome
AF:
AC:
4725
AN:
152302
Hom.:
Cov.:
31
AF XY:
AC XY:
2269
AN XY:
74462
show subpopulations
African (AFR)
AF:
AC:
4420
AN:
41562
American (AMR)
AF:
AC:
190
AN:
15298
Ashkenazi Jewish (ASJ)
AF:
AC:
4
AN:
3470
East Asian (EAS)
AF:
AC:
0
AN:
5184
South Asian (SAS)
AF:
AC:
28
AN:
4828
European-Finnish (FIN)
AF:
AC:
1
AN:
10618
Middle Eastern (MID)
AF:
AC:
2
AN:
294
European-Non Finnish (NFE)
AF:
AC:
40
AN:
68024
Other (OTH)
AF:
AC:
40
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
218
436
653
871
1089
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
34
AN:
3478
ClinVar
Significance: Benign/Likely benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Nov 14, 2019
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
not specified Benign:1
-
PreventionGenetics, part of Exact Sciences
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
RBP_binding_hub_radar
RBP_regulation_power_radar
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at